論文・技術情報追加のお知らせ

①Post-Marketing Safety Concerns with Nirmatrelvir: A Disproportionality Analysis of Spontaneous Reports Submitted to FDA Adverse Event Reporting System.

ニルマトレルビルの安全性調査、不均衡分析研究

対象DB：FAERS

②Signal mining and analysis for central nervous system adverse events due to taking oxycodone based on FAERS database.

オキシコドン単独または、併用使用による中枢神経系有害事象のリスク調査研究

対象DB：FAERS

③Myocarditis and pericarditis recovery following smallpox vaccine 2002-2016: A comparative observational cohort study in the military health system.

天然痘ワクチン接種後の心筋炎、心膜炎の臨床特性および長期転帰の調査報告

対象DB：VAERS

④Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system.

COVID-19感染症患者における、レムデシビルに関連する腎臓および心臓の有害事象調査研究

対象DB：FAERS

⑤Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: A Pharmacovigilance Study Based on the FAERS Database.

多発性骨髄腫患者におけるTLSとmAbsの関連性調査、不均衡分析研究

対象DB：FAERS

⑥CAR-T Cells and the Kidney: Insights from the WHO Safety Database.

CAR-T細胞療法の腎臓への影響評価研究

対象DB：VigiBase

⑦An explorative analysis of pharmacovigilance data of oxytocin and its analogue carbetocin, with a focus on haemodynamic adverse effects.

オキシトシンおよびカルベトシンにおける血行動態関連の有害事象調査研究

対象DB：VigiBase